Company profile for Synermore Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Synermore Biologics founded in 2016 and backed by SINOVAC, focuses on R&D, production, and sales of innovative monoclonal antibody drugs and biosimilars. With a mission to "Supply Medicine to Eliminate Human Diseases," the company targets cancer, autoimmune, and infectious diseases. It has built a full industrial chain for antibody drugs, supported by a global team experienced in drug development and GMP compliance. Synermore ...
Synermore Biologics founded in 2016 and backed by SINOVAC, focuses on R&D, production, and sales of innovative monoclonal antibody drugs and biosimilars. With a mission to "Supply Medicine to Eliminate Human Diseases," the company targets cancer, autoimmune, and infectious diseases. It has built a full industrial chain for antibody drugs, supported by a global team experienced in drug development and GMP compliance. Synermore holds 12 China patents (10 granted) and several global patents. It aims to become a globally competitive biopharma innovator through continuous product launches and quality growth.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Building 5, No. 218, Sangtian Street, Suzhou Industrial Park 215000, Jiangsu P...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty